CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation
- Conditions
- Chronic Thromboembolic Pulmonary HypertensionPulmonary Embolism
- Registration Number
- NCT04681014
- Lead Sponsor
- iPHNET (italian Pulmonary Hypertension NETwork)
- Brief Summary
CTEPH-SOLUTION aims to create a risk score for the early detection of Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH) among patients with previous pulmonary embolism.
The risk score, created on retrospective data, will be validated on newly diagnosed pulmonary embolism patients.
- Detailed Description
CTEPH-SOLUTION is a multicenter observational cross-sectional and prospective study in patients with a prior and new diagnosis of pulmonary embolism.
Patients with prior pulmonary embolism will be screened at baseline with doppler echocardiography: an estimated sPAP ≥ 40 mmHg will be the indication for pulmonary hypertension detection. After 24 months from baseline, patients will be followed-up for CTEPH detection. CTEPH diagnosis will be carried out according to the current ESC/ERS guidelines.
Incident (pulmonary embolism episode at least three months before the baseline) and prevalent (pulmonary embolism episode) patients will be enrolled.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1218
- Age ≥ 18 at baseline evaluation
- Diagnosis of prior (> 30 days from pulmonary embolism onset) or new-onset pulmonary embolism, according to the ESC guidelines on the diagnosis and management of acute pulmonary embolism
- patients without pulmonary embolism diagnosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CTEPH-SOLUTION score 24 months The CTEPH-SOLUTION score will be created on retrospective parameters (i.e., demographic data, diagnostic and clinical information, risk factors, laboratories parameters) collected on pulmonary embolism patients.
The minimum and maximum values will be defined after the multivariate statistical analysis, and the risk factors analyzed a posteriori. Higher scores mean a worse outcome.
- Secondary Outcome Measures
Name Time Method The number of the subject with a diagnosis of CTEPH on the total number of subjects enrolled. 24 months
Trial Locations
- Locations (1)
Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences. AOU Policlinico Umberto I
🇮🇹Rome, Italy